文献速递慢性肾脏病肾小球疾病

全皮质间质炎症预测狼疮性肾炎患者的慢性肾脏病进展

Total cortical interstitial inflammation predicts chronic kidney disease progression in patients with lupus nephritis.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

该回顾性队列纳入125例狼疮性肾炎(LN)患者,比较全皮质间质炎症评分与NIH间质炎症评分对慢性肾脏病(CKD)进展的预测价值。中重度全皮质间质炎症28例(22.4%),中重度NIH间质炎症8例(6.4%);46例发生CKD进展。校正混杂因素后,全皮质间质炎症与CKD进展相关(HR 2.45,95%CI 1.2-4.97),而NIH间质炎症与CKD进展无关联。

要点

  • 全皮质间质炎症评分可识别LN患者CKD进展风险,校正后HR为2.45(95%CI 1.2-4.97)。
  • NIH间质炎症分类与CKD进展无关联,提示其预测价值有限。
  • 中重度全皮质间质炎症占22.4%,中重度NIH间质炎症仅占6.4%。

核心结论

  • 与现行NIH间质炎症分类不同,评估整个皮质实质的间质炎症有助于识别LN患者中CKD进展风险人群。

研究设计与样本

  • 回顾性队列研究,纳入2005年至2018年索引肾活检为LN III型、IV型、V型或混合型(III/V、IV/V)的125例系统性红斑狼疮(SLE)患者。
  • 肾活检按2018年NIH活动性指数(AI)及肾小管间质病变分类重新审阅评分。

主要发现

  • 125例患者中46例发生CKD进展,其中21例后续发展为终末期肾病(ESKD)。
  • 28例(22.4%)为中重度全皮质间质炎症,8例(6.4%)为中重度NIH间质炎症。
  • 进展者与非进展者基线特征无差异。
  • 校正活检时年龄、种族、性别、LN分型及肾活检高血压性血管改变后,全皮质间质炎症与CKD进展相关(HR 2.45,95%CI 1.2-4.97)。
  • NIH间质炎症与CKD进展无关联。

关键数值与推荐

  • 全皮质间质炎症按整个皮质实质炎症浸润面积分级:0级为<10%,1级为10-25%,2级为26-50%,3级为>50%(类似Banff总炎症评分定义)。
  • CKD进展定义为索引肾活检后5年内估算肾小球滤过率下降≥30%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: End-stage kidney disease (ESKD) from lupus nephritis (LN) is a major cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Kidney biopsy is the gold standard for diagnosis and prognostication of LN. While interstitial fibrosis and tubular atrophy (IFTA) predict progression to ESKD, the National Institutes of Health (NIH) classification of interstitial inflammation in unscarred cortical parenchyma is not predictive of chronic kidney disease (CKD) progression. The objective of this study was to determine whether total cortical interstitial inflammation that accounts for inflammation in the entire cortical parenchyma could predict CKD progression in patients with LN. Early identification of at-risk patients may improve outcomes. METHODS: This retrospective cohort study included 125 SLE patients with LN class III, IV, V or mixed (III/V, IV/V) on the index biopsy (2005-2018). Kidney biopsies were reviewed and assigned based on the 2018 NIH Activity Index (AI) and tubulointerstitial lesion categories. Total interstitial inflammation in the entire cortical parenchyma was graded as 0, 1, 2 or 3, corresponding to <10%, 10-25%, 26-50% and >50%, respectively, of the total cortical parenchyma containing an inflammatory infiltrate (similar to the definition used in the Banff total inflammation score). CKD progression was defined as an estimated glomerular filtration rate decrease of ≥30% within 5 years after the index biopsy. Kaplan-Meier survival curves and Cox proportional hazards models were performed to compare the two scoring systems, the total cortical intestinal inflammation score and the NIH interstitial inflammation score as predictors of CKD progression. RESULTS: Of 125 patients, 46 experienced CKD progression; 21 of 46 subsequently developed ESKD, 28 (22.4%) had moderate-severe total cortical interstitial inflammation and 8 (6.4%) had moderate-severe NIH interstitial inflammation. There were no differences in baseline characteristics between progressors and nonprogressors. Total cortical interstitial inflammation was associated with CKD progression in time-dependent analyses [hazard ratio 2.45 (95% confidence interval 1.2-4.97)] adjusted for age at biopsy, race, sex, LN class and hypertensive vascular change on kidney biopsy. The NIH interstitial inflammation was not associated with CKD progression. CONCLUSIONS: In contrast to the current NIH interstitial inflammation classification, accounting for interstitial inflammation in the entire cortical parenchyma allows identification of patients at risk for CKD progression in LN.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Duong MD, Wang S, Schwartz D, et al. Total cortical interstitial inflammation predicts chronic kidney disease progression in patients with lupus nephritis. Nephrol Dial Transplant. 2023. PMID: 36220148. doi:10.1093/ndt/gfac286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。